[home]
[thesaurus]
Click Here to return To Results
Sustained-Release Oral Fampridine in Multiple Sclerosis: A Randomised, Double-Blind, Controlled Trial
Lancet 373:732-738, Goodman,A.D.,et al, 2009
See this aricle in Pubmed
Article Abstract
Fampridine improved walking ability in some people with multiple sclerosis. This improvement was associated with a reduction of patients� reported ambulatory disability, and is a clinically meaningful therapeutic benefit.
Related Tags
(click to filter results - removes previous filter)
aminopyridine,4
efficacy
multiple sclerosis
multiple sclerosis,treatment of
safety
treatment of neurologic disorder
Click Here to return To Results